SCHEMBL7655262

SCHEMBL7655262

COc1ccc2c(c1)C(N1CCCC1=O)NN=C2Cc1ncc(Cl)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LIPE Q05469 1/20 0.32
F10 P00742 4/20 0.32
TNF P01375 1/20 0.32
PDE4A P27815 5/20 0.31
PDE4B Q07343 5/20 0.31
PDE4C Q08493 5/20 0.31
PDE4D Q08499 5/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
RECQL P46063 1/20 0.31
PDCD1 Q15116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6586405 0.85 PDE4A (0.45) PDE4APDE4BPDE4CPDE4D
SCHEMBL7655256 0.73 MAPT (0.35) ALDH1A1MAPTL3MBTL1KDM4EHPGD
SCHEMBL17664012 0.62 SMN1; SMN2 (0.50) ALDH1A1MAPTPOLBSMN1; SMN2CYP2C9
SCHEMBL6586401 0.62 PDE4A (0.39) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL6588385 0.60 PDE4A (0.48) PDE4APDE4BPDE4CPDE4D
SCHEMBL4518720 0.59 MTNR1B (0.56) KDM4E
SCHEMBL9701845 0.59 ABCC9 (0.43) MAPTKDM4ESMN1; SMN2CYP1A2CYP2C9
SCHEMBL9587862 0.59 ABCC9 (0.43) MAPTKDM4ESMN1; SMN2CYP1A2CYP2C9
SCHEMBL3950819 0.56 OPRM1 (0.38) ALDH1A1CD274
SCHEMBL7816033 0.55 TP53 (0.48) ALDH1A1MAPTHPGDPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492360-B1 Phthalazine derivatives phosphodiesterase 4 inhibitors ZAMBON GROUP S.P.A. (IT) 2002-12-10 US disclosed